A detailed history of Barry Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Barry Investment Advisors, LLC holds 2,145 shares of ABT stock, worth $245,023. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,145
Previous 2,160 0.69%
Holding current value
$245,023
Previous $224,000 8.93%
% of portfolio
0.08%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$100.07 - $118.13 $1,501 - $1,771
-15 Reduced 0.69%
2,145 $244,000
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $100 - $112
1 Added 0.05%
2,160 $224,000
Q1 2024

Apr 17, 2024

SELL
$109.52 - $120.96 $16,975 - $18,748
-155 Reduced 6.7%
2,159 $245,000
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $18,128 - $22,190
-201 Reduced 7.99%
2,314 $254,000
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $2,197 - $2,636
-23 Reduced 0.91%
2,515 $243,000
Q2 2023

Aug 02, 2023

SELL
$100.78 - $112.29 $2,418 - $2,694
-24 Reduced 0.94%
2,538 $276,000
Q1 2023

Apr 27, 2023

BUY
$96.86 - $114.01 $484 - $570
5 Added 0.2%
2,562 $259,000
Q4 2022

Jan 25, 2023

BUY
$95.06 - $111.52 $11,597 - $13,605
122 Added 5.01%
2,557 $0
Q3 2022

Oct 24, 2022

BUY
$96.76 - $112.03 $3,870 - $4,481
40 Added 1.67%
2,435 $236,000
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $140,958 - $170,373
-1,381 Reduced 36.57%
2,395 $260,000
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $38,766 - $47,273
340 Added 9.9%
3,776 $447,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $120,266 - $147,259
1,041 Added 43.47%
3,436 $484,000
Q3 2021

Oct 29, 2021

BUY
$116.66 - $129.06 $699 - $774
6 Added 0.25%
2,395 $283,000
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $55,539 - $65,378
525 Added 28.17%
2,389 $277,000
Q1 2021

Apr 19, 2021

BUY
$108.84 - $128.23 $202,877 - $239,020
1,864 New
1,864 $223,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Barry Investment Advisors, LLC Portfolio

Follow Barry Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barry Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barry Investment Advisors, LLC with notifications on news.